Oncotelic Therapeutics, Inc. Preferred Stock Dividends, Income Statement Impact
Oncotelic Therapeutics, Inc. (OTLC) reported Preferred Stock Dividends, Income Statement Impact of $4.80 million for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2015-03-30
- Oncotelic Therapeutics, Inc. preferred stock dividends, income statement impact for the quarter ending 2013-12-31 was $0.00.
- Oncotelic Therapeutics, Inc. preferred stock dividends, income statement impact for the quarter ending 2013-09-30 was $2.32M.
- Oncotelic Therapeutics, Inc. preferred stock dividends, income statement impact for the quarter ending 2013-06-30 was $2.48M.
- Oncotelic Therapeutics, Inc. preferred stock dividends, income statement impact for fiscal 2013 was $4.80M.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $2.32M derived: sum of 2 quarters · filed 2015-03-30 | $4.80M derived: sum of 3 quarters · filed 2015-03-30 | $4.80M 10-K · filed 2015-03-30 |
| 2013-09-30 | $2.32M 10-Q · filed 2014-11-13 | $4.80M derived: sum of 2 quarters · filed 2014-11-13 | $4.80M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $2.48M 10-Q · filed 2014-08-08 | $2.48M 10-Q · filed 2014-08-08 |